HEALTH OF WOMAN. 2020.5-6(151-152): 48-53; doi 10.15574/HW.2020.151-152.48
 Zahorodnya O. S.², Bila V. V.^1,2, Yarotska Y. O.¹, Klyushanova O. I.³, Akimova O. V.^1
1Perinatal center of Kyiv
²Bogomolets National Medical University, Kiev
³A-UPO «Art Therapeutic Association», Kyiv

The article presents the experience of the project on physical and psychological recovery of families after reproductive losses. The concept of fetal loss syndrome was chosen as a principle of the project, which provides both common pathogenetic mechanisms of early and late miscarriage, spontaneous and induced premature birth, which lead to neonatal death, and similar mechanisms of psychological experience of reproductive loss due to the lack of formed connection between parents and child.
The main etiological factors of miscarriage, the principles of their diagnosis and the applied algorithm of treatment are considered. In particular, a detailed description of the role of progesterone deficiency in the mechanisms of miscarriage and severe obstetric complications is given, the debatability of the effectiveness of unjustified prescribing of exogenous progesterone, both from a molecular and epidemiological point of view. Attention is paid to thrombophilias of various origins, which is currently one of the recognized factors of miscarriage.
The results of the project are presented, which include more than 20 meetings held in 3 years, as a result of which 20 couples were planned to have the next pregnancy and its observation. All 20 cases were completed in the Perinatal Center by timely delivery with the birth of a living healthy child, so all pregnancies became maternity.
Keywords: Kyiv Perinatal Center, miscarriage, reproductive losses, pregnancy, thrombophilia, progesterone deficiency, psychology.

REFERENCES

1. Abdulaev RYa, Golovko TS. 2009. Ultrasonografiya. Harkov, Nove slovo:180.

2. Andreichyn MA, Chopiak VV, Hospodarskyi IIa. 2005. Imunolohichna tolerantnist ta imunolohiia reproduktsii (v kn. Klinichna imunolohiia ta alerholohiia). Ternopil, Ukrmedknyha:175–179.

3. Ventskivska IB, Vitovskyi YaM, Zahorodnia OS. 2017. Novi pidkhody do otsinky stanu platsentarnoho krovoobihu pry tiazhkykh formakh preeklampsii. Zbirnyk naukovykh prats asotsiatsii akusheriv-hinekolohiv Ukrainy 2(40):40–45.

4. Veropotvelyan NP, Kodunov LA, Pogulyay YuS. 2016. Chastota vstrechaemosti polimorfizma S677T gena MTHFR u zhenschin s defektami nevralnoy trubki u ploda i podhody k individualnoy prekontseptsionnoy profilaktike. Zdorove zhenschiny 1(107):99–102.

5. Zhuk SI, Kalinka Ya, Sidelnikova VM. 2017. Nevyinashivanie beremennosti: novyi vzglyad na staruyu problemu. Zdorove Ukrainy 5(1):35.

6. Mayorov MV. 2004. Gestagenyi v akushersko-ginekologicheskoy praktike. Provizor 7:26–29.

7. Streltsova TR, Simonova NR. 2019. Klinicheskiy opyt negormonalnoy korrektsii nedostatochnosti lyuteinovoy fazy u zhenschin reproduktivnogo vozrasta. Zdorove zhenschiny 4(140):24–26.

8. Azem F, Many A, Ben Ami I, Yovel I, Amit A et al. 2004. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 19(2):368-70. https://doi.org/10.1093/humrep/deh069; PMid:14747183

9. Bowen V, Su J, Torrone E et al. 2010. Increase in incidence of congenital syphilis: United States, 2012-2014. MMWR Morb Mortal Wkly Rep. 59:413-417. https://doi.org/10.15585/mmwr.mm6444a3; PMid:26562206

10. Bykowska K, Vertun-Baranowska B, Windyga J, Łopaciuk S. 2000. Prevalence of G20210A prothrombin gene mutation in Poland. Pol Arch Med Wewn. 104:729-733.

11. Chang-Zhu Pei, Young Ju Kim, Kwang-Hyun Baek. 2019. Pathogenetic factors involved in recurrent pregnancy loss from multiple aspects. Obstet Gynecol Sci. 62(4):212-223. https://doi.org/10.5468/ogs.2019.62.4.212; PMid:31338338 PMCid:PMC6629979

12. Clayton P, Herjanic M. 1974. Mourning and depression: Their similarities and differences. Can. Psychiatr. Assoc. J. 19:309-312. https://doi.org/10.1177/070674377401900312; PMid:4841049

13. Coomarasamy A, Devall A, Cheed V, Harb H, Middleton L et al. 2019. A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy. N Engl J Med. 380:1815-1824. https://doi.org/10.1056/NEJMoa1813730; PMid:31067371

14. Erden O, Imir A, Guvenal T, Muslehiddinoglu A, Arici S, Cetin M, Cetin A. 2006. Іnvestigation of the effects of heparin and low molecular weight heparin on E-cadherin and laminin expression in rat pregnancy by immunohistochemistry. Hum Reprod. 21(11):3014-8. https://doi.org/10.1093/humrep/del262; PMid:16997938

15. Gomez-Lopez N, Romero R, Plazyo O et al. 2017. Preterm labor in the absence of acute histologic chorioamnionitis is characterized by cellular senescence of the chorioamniotic membranes. Am J Obstet Gynecol. 217:592.e1-17. https://doi.org/10.1016/j.ajog.2017.08.008; PMid:28847437 PMCid:PMC5800423

16. Hirsh J, Anand S, Halperin J, Fuster V. 2001. Мechanism of action and pharmacology of unfractionated heparin. Arterioscler Thromb Vasc Biol. 21(7):1094-6. https://doi.org/10.1161/hq0701.093686; PMid:11451734

17. Gordon CS, Smith MD. 2015. Prevention of stillbirth. The obstetricians and gynecologist. 17:183-7. https://doi.org/10.1111/tog.12197

18. Han C, Mulla M, Brosens J, Chamley L, Paidas MJ, Lockwood CJ, Abrahams VM. 2011. Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function. Obstet Gynecol. 118(5):1021-8. https://doi.org/10.1097/AOG.0b013e31823234ad; PMid:22015869 PMCid:PMC3199133

19. Kim YS, Kim MS, Lee SH, Choi BC, Lim JM, Cha KY. 2006. Proteomic analysis of recurrent spontaneous abortion: identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics. 6:3445-3454. https://doi.org/10.1002/pmic.200500775; PMid:16637005

20. Leush S, Ventskivs'ka I, Zahorodnia O. 2019. The structure of antiphospholipid antibodies circulation investigated in pregnancy I and II trimester. Zdorove zhenschiny 4(140):55-58.

21. Management of premenstrual syndrome. Green-top Giudeline. Royal College of Obstetricians and Gynecologists. BJOG. 48. 2016.

22. Margalioth EJ, Ben-Chetrit A, Gal M, Eldar-Geva T. 2006. Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod. 21:3036-43. https://doi.org/10.1093/humrep/del305; PMid:16905766

23. Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet J et al. 2009. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution. Blood Coagul Fibrinolysis. 20(7):503-510. https://doi.org/10.1097/MBC.0b013e32832f5d7a; PMid:19730248

24. Morales-Borges J. 2014. Prevalence of MTHFR C677T and A1298C Mutations and Thrombophilia in Puerto Rico. J Blood Disorders Transf. 5:5-7. https://doi.org/10.4172/2155-9864.1000213

25. Sogutlu S, Yazici A, Eser B, Erol M, Kilic A et al. 2014. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels. Cutan Ocul Toxicol. 33(4):270-4. https://doi.org/10.3109/15569527.2013.854372; PMid:24446892

26. Stafford I, Sánchez P, Stoll B. 2019, November 11. Ending Congenital Syphilis. JAMA. Published online. https://doi.org/10.1001/jama.2019.17031; PMid:31710335

27. Szekeres-Bartho J, Barakonyi A, Par G. 2001. Progesterone as an immunomodulatory molecule. Jnt. Immunopharmacol. 1(6):1037-1048. https://doi.org/10.1016/S1567-5769(01)00035-2

28. Tsikouras P, Deftereou T, Anthoulaki X, Bothou A, Chalkidou A et al. Thrombophilia and Pregnancy: Diagnosis and Management. Intech Open, DOI: 10.5772/intechopen.85005. https://www.intechopen.com/online-first/thrombophilia-and-pregnancy-diagnosis-and-management

29. Visser J, Ulander V, Helmerhorst F, Lampinen K, Morin-Papunen L, Bloemenkamp K, Kaaja R. 2011. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb Haemost. 105(2):295-301. https://doi.org/10.1160/TH10-05-0334; PMid:21103659

30. Worden J. 2008. Grief Counseling and Grief Therapy //A Handbook for the Mental Health Practitioner, Fourth Edition Publisher: Springer Publishing Company, Incorporated: 248. https://doi.org/10.1891/9780826101211

31. Yuksel H, Kayatas S, Boza A, Api M, Ertekin A, Cam C. 2014. Low molecular weight heparin use in unexplained recurrent miscarriage. Pak J Med Sci. 30(6):1232-1237. https://doi.org/10.12669/pjms.306.5477; PMid:25674114 PMCid:PMC4320706